Diagnostic accuracy of osteopontin plus alpha-fetoprotein in the hepatocellular carcinoma: A meta-analysis - 15/12/17
pages | 11 |
Iconographies | 6 |
Vidéos | 0 |
Autres | 0 |
Summary |
Objective |
Osteopontin (OPN) has been reported as a potential biomarker for diagnosis of hepatocellular carcinoma (HCC) in many inconsistent results. This study demonstrates a systematic meta-analysis for the evaluation on diagnostic accuracy of serum or plasma OPN and alpha-fetoprotein (AFP) alone and combined assays for HCC.
Methods |
Relevant literatures were searched in PubMed up to August 2016. The quality of each study was evaluated by QUADAS-2 (quality assessment for studies of diagnostic accuracy). Statistical analysis was performed by Meta-Disc 1.4 and Stata 12.0. The random-effect models were used to estimate pooled sensitivity, specificity and other diagnostic indicators of OPN and/or AFP in HCC.
Results |
A total of 14 case-control literatures (15 studies) met the inclusion criteria in this meta-analysis. The respective pooled diagnostic sensitivity and specificity were 0.71 (95% CI: 0.69–0.74) and 0.80 (95% CI: 0.78–0.82) for OPN; 0.61 (95% CI: 0.58–0.63) and 0.92 (95% CI: 0.91–0.94) for AFP; 0.82 (95% CI: 0.79–0.84) and 0.77 (95% CI: 0.74–0.80) for OPN plus AFP. Their area under the curve (AUC) values were 0.8786, 0.8718 and 0.9005, respectively.
Conclusion |
Combination of OPN and AFP was better than OPN or AFP alone in diagnosis of HCC.
Le texte complet de cet article est disponible en PDF.Abbreviations : AFP, CLD, HCC, HBV, HCV, OPN, AFP-L3, DCP, GPC-3, DKK-1, GP73
Plan
Vol 41 - N° 5
P. 543-553 - octobre 2017 Retour au numéroBienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’achat d’article à l’unité est indisponible à l’heure actuelle.
Déjà abonné à cette revue ?